UPDATED Apr 26, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ELF | US$179.63 | 14.6% | 93.7% | US$10.0b | US$206.21 | PE77.1x | E27.2% | n/a | ||
LQWC | US$0.017 | 8.5% | -40.1% | US$2.1m | n/a | PS14.4x | n/a | n/a | ||
MED | US$33.71 | 3.9% | -63.2% | US$363.4m | US$37.50 | PE3.7x | E-63.2% | 0% | ||
INBP | US$0.21 | 0% | -43.4% | US$6.5m | n/a | PB0.3x | n/a | n/a | ||
ODD | US$32.19 | -3.9% | n/a | US$1.8b | US$52.69 | PE31.3x | E20.2% | n/a | ||
SLGD | US$0.94 | -9.6% | 347.6% | US$12.2m | n/a | PS3.6x | n/a | n/a | ||
GHSI | US$7.90 | -1.1% | 40.3% | US$10.1m | n/a | PE64.2x | E-72.2% | n/a | ||
HNST | US$3.16 | 4.3% | 90.4% | US$306.6m | US$4.55 | PB2.5x | E69.3% | n/a | ||
AXIL | US$11.20 | -3.4% | 36.3% | US$65.8m | n/a | PE24.3x | n/a | n/a | ||
DQWS | US$0.013 | 0% | -91.7% | US$2.6m | n/a | PS1.8x | n/a | n/a | ||
UG | US$8.27 | 3.2% | -14.1% | US$38.0m | n/a | PE14.7x | n/a | 4.2% | ||
NATR | US$19.50 | 1.1% | 77.9% | US$367.0m | US$24.00 | PE24.3x | E10.8% | 0% | ||
WDFC | US$225.52 | -1.9% | 18.4% | US$3.1b | US$282.23 | PE44.8x | E11.5% | 1.6% | ||
NHTC | US$6.57 | -1.6% | 6.5% | US$75.3m | n/a | PE132.5x | n/a | 12.2% | ||
LFVN | US$6.19 | -7.7% | 87.4% | US$79.6m | n/a | PE26.9x | S4.0% | 2.3% | ||
SPB | US$82.57 | 2.7% | 24.2% | US$2.5b | US$92.79 | PB1.1x | E53.1% | 2.0% | ||
ODC | US$68.75 | -0.4% | 62.2% | US$501.0m | n/a | PE12.1x | n/a | 1.7% | ||
VERU | US$1.27 | -3.1% | 0% | US$185.9m | US$3.33 | PS11.7x | E1.7% | 0% | ||
THRN | US$10.19 | 0.1% | 128.5% | US$550.6m | US$8.60 | PE27.1x | E57.2% | n/a | ||
FLGC | US$1.36 | -12.8% | -68.3% | US$17.4m | US$6.00 | PB2.7x | E144.3% | n/a | ||
IPAR | US$119.56 | -6.5% | -21.2% | US$3.8b | US$169.97 | PE25.1x | E8.9% | 2.5% | ||
CVSI | US$0.038 | -5.4% | -19.6% | US$6.1m | n/a | PE2x | n/a | n/a | ||
PGID | US$0.11 | 0% | 80.3% | US$27.7m | n/a | PS1330.9x | n/a | n/a | ||
NUS | US$12.31 | -5.4% | -68.8% | US$611.4m | US$14.50 | PE71.1x | E74.1% | 1.9% |